<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04598841</url>
  </required_header>
  <id_info>
    <org_study_id>TJH-HSCRNS</org_study_id>
    <nct_id>NCT04598841</nct_id>
  </id_info>
  <brief_title>Nutrition Support for Hirschsprung Disease</brief_title>
  <official_title>A Multicentric Study on Perioperative Nutritional Support for Hirschsprung's Disease</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Tongji Hospital</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Tongji Hospital</source>
  <oversight_info>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      A multi-center, prospective, real-world, non-randomized, non-blind, controlled study was&#xD;
      conducted to investigate the effects of different perioperative nutritional support modes on&#xD;
      perioperative nutritional status, surgical treatment success rate, and rehabilitation process&#xD;
      in children with Hirschsprung disease.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">January 1, 2021</start_date>
  <completion_date type="Anticipated">December 31, 2026</completion_date>
  <primary_completion_date type="Anticipated">December 31, 2025</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Other</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Z score</measure>
    <time_frame>2 years</time_frame>
    <description>weight/ height</description>
  </primary_outcome>
  <enrollment type="Anticipated">1000</enrollment>
  <condition>Nutrition Supporting</condition>
  <condition>Hirschsprung Disease</condition>
  <condition>Infants</condition>
  <condition>Prospective Study</condition>
  <intervention>
    <intervention_type>Dietary Supplement</intervention_type>
    <intervention_name>supplement nutritional supporting</intervention_name>
    <description>Special medical formula for the purpose of formula food</description>
  </intervention>
  <eligibility>
    <study_pop>
      <textblock>
        Infants diagnosed with Hirschsprung disease who need supplement nutritional support.&#xD;
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          1. Children aged 0-2 years.&#xD;
&#xD;
          2. Clinical diagnosis with Hirschsprung's disease who requires surgery;&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          1. Complicated with severe complications such as enterocolitis associated with&#xD;
             Hirschsprung disease;&#xD;
&#xD;
          2. History of diseases associated with various organ systems that may be&#xD;
             life-threatening;&#xD;
&#xD;
          3. Other severe digestive tract malformations or other diseases that may interfere with&#xD;
             the treatment or compliance of the child;&#xD;
&#xD;
          4. Patients who have participated in other clinical trials within the last 1 month;&#xD;
&#xD;
          5. Any other conditions in which the investigator considers it inappropriate to&#xD;
             participate in the trial.&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>N/A</minimum_age>
    <maximum_age>2 Years</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_contact>
    <last_name>Jiexiong Feng</last_name>
    <phone>0086-2783665309</phone>
    <email>fengjiexiong@126.com</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Tianqi Zhu</last_name>
    <phone>0086-2783665309</phone>
    <email>zhutianqi84@163.com</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>Tongji Hospital</name>
      <address>
        <city>Wuhan</city>
        <state>Hubei</state>
        <zip>430000</zip>
        <country>China</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Tianqi Zhu</last_name>
      <phone>0086-27833665309</phone>
      <email>zhutianqi84@163.com</email>
    </contact>
  </location>
  <location_countries>
    <country>China</country>
  </location_countries>
  <verification_date>March 2021</verification_date>
  <study_first_submitted>October 18, 2020</study_first_submitted>
  <study_first_submitted_qc>October 18, 2020</study_first_submitted_qc>
  <study_first_posted type="Actual">October 22, 2020</study_first_posted>
  <last_update_submitted>March 29, 2021</last_update_submitted>
  <last_update_submitted_qc>March 29, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">April 1, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Tongji Hospital</investigator_affiliation>
    <investigator_full_name>Jiexiong Feng</investigator_full_name>
    <investigator_title>professor</investigator_title>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hirschsprung Disease</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

